A 35-Year-Old Woman Presents With Gastric Pain

Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis

Investigators will present detailed results from the phase 3 FORTITUDE-101 trial at a future medical meeting.

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

Benjamin J. Golas, MD

June 30th 2025

Video-Based Genetic Counseling Improves Comprehension in HBOC

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.

Tim Cortese

Practice-Changing Lung Cancer Data From the 2025 ASCO Annual Meeting

In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.

Stephen Liu, MD, and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.

Stephen V. Liu, MD;Joshua K. Sabari, MD

June 23rd 2025

16 A Miami Hospital’s Infrastructure to Help Decrease Late-Stage Breast Cancer Diagnosis and Improve Health Equity

Stephen Liu, MD; and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.

Yolcar Chamorro;Ana Sandoval Leon, MD;Cynthia Thiry;Barbara Gallo;Sherine Mitchell;Alejandro Larios Venegas

Comparing CAR T Safety, Efficacy in Relapsed/Refractory Multiple Myeloma

$The expert panel discussed the efficacy observed with cilta-cel in patients with relapsed/refractory multiple myeloma.$

Roman Fabbricatore

Bemarituzumab Regimen Improves Survival in FGFR2b+ Gastric/GEJ Cancer

The expert panel discussed the efficacy observed with cilta-cel in patients with relapsed/refractory multiple myeloma.

Related Content

Russ Conroy

Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis

Investigators will present detailed results from the phase 3 FORTITUDE-101 trial at a future medical meeting.

Benjamin J. Golas, MD

June 30th 2025

Video-Based Genetic Counseling Improves Comprehension in HBOC

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

Tim Cortese

Practice-Changing Lung Cancer Data From the 2025 ASCO Annual Meeting

In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.

Stephen V. Liu, MD;Joshua K. Sabari, MD

June 23rd 2025

16 A Miami Hospital’s Infrastructure to Help Decrease Late-Stage Breast Cancer Diagnosis and Improve Health Equity

Stephen Liu, MD; and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.

Yolcar Chamorro;Ana Sandoval Leon, MD;Cynthia Thiry;Barbara Gallo;Sherine Mitchell;Alejandro Larios Venegas

Comparing CAR T Safety, Efficacy in Relapsed/Refractory Multiple Myeloma

$The expert panel discussed the efficacy observed with cilta-cel in patients with relapsed/refractory multiple myeloma.$

Roman Fabbricatore